{"id":"b515d63e-5a11-48b6-91c5-b93a47540d5e","kind":"news","code":"b515d63e-5a11-48b6-91c5-b93a47540d5e","name":"Phil Rivers completes strategic financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"哲源科技完成战略投资融资","eventDate":"2024-12-12T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T21:00:16.423Z","englishUpdatedAt":"2026-10-15T17:19:59.889Z","reviewedAt":"2026-10-15T17:19:59.889Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"2d002dc3ac7ad89ca760f1694a9fda8420f05d438bc56c21fa90246f8dc27f64","companyId":"379cea5b-ef8c-4bca-a8e9-dac76fb4710d","foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"379cea5b-ef8c-4bca-a8e9-dac76fb4710d","kind":"companies","code":"UB-C3525","name":"Phil Rivers","nameBasis":"source-english","summary":"Provider of solutions for AI pharmaceutical research and development.","description":"Zheyuan Technology is an AI pharmaceutical research and development solutions provider","country":"China","category":null,"originalName":"哲源科技","eventDate":null,"website":"https://www.philrivers.com/","sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-15T20:38:52.104Z","reviewedAt":"2026-10-15T20:38:52.104Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dbab255f1f6a665b5cce8060f9f4230e9924480f12948619228f25e905e4252a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/zheyuankeji"},{"id":"665ccc2d-256d-41cf-8b63-1f626acf329b","kind":"institutions","code":"UB-I3936","name":"Tuohaihongfang","nameBasis":"transliterated","summary":"Tuohaihongfang is a Chinese private equity firm, focused on equity investment in growth-stage and mature unlisted companies.","description":"Tuohaihongfang is a Chinese private equity firm, focused on equity investment in growth-stage and mature unlisted companies.","country":null,"category":null,"originalName":"拓海鸿方","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:46:29.265Z","englishUpdatedAt":"2026-10-15T18:43:03.648Z","reviewedAt":"2026-10-15T18:43:03.648Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"674d24ee26833041d1b6e790f92d45d3df138a62a097be47c45f3b668871c3a1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/tuohaihongfang"}],"path":"/news/b515d63e-5a11-48b6-91c5-b93a47540d5e","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Phil Rivers","path":"/companies/zheyuankeji"}},"canonical":"https://uniquebase.ai/news/b515d63e-5a11-48b6-91c5-b93a47540d5e"}